Literature DB >> 4264517

Systemic lupus erythematosus in a patient with ultrastructural lesions of the pulmonary capillaries previously reported in the review as due to idiopathic pulmonary hemosiderosis.

C Kuhn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4264517     DOI: 10.1164/arrd.1972.106.6.931a

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  8 in total

Review 1.  Small vessel vasculitis of the lung.

Authors:  M I Schwarz; K K Brown
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  Immunoglobulin and complement deposits in the lungs of New Zealand Black/White mice.

Authors:  D M Geddes; A J Leathem
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-07-26

3.  Pulmonary veno-occlusion--an immune complex disease?

Authors:  B Corrin; H Spencer; M Turner-Warwick; S J Beales; J J Hamblin
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

4.  Idiopathic pulmonary haemosiderosis: report of two cases and review of the literature.

Authors:  P Bailey; B M Groden
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

Review 5.  The ultrastructure of human fibrosing alveolitis.

Authors:  J J Coalson
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

6.  Progressive systemic sclerosis complicated by diffuse pulmonary haemorrhage.

Authors:  J Kallenbach; I Prinsloo; S Zwi
Journal:  Thorax       Date:  1977-12       Impact factor: 9.139

7.  Sex hormones modulate the response of pulmonary perivascular inflammation to cyclophosphamide therapy in MRL/MpJ-lpr/lpr mice.

Authors:  W N McKenzie; E V Sunderrajan; J L Kavanaugh; S Braun; L Ansbacher; S E Walker
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

8.  Experimental immune complex disease of the lung. The pathogenesis of a laboratory model resembling certain human interstitial lung diseases.

Authors:  J R Brentjens; D W O'Connell; I B Pawlowski; K C Hsu; G A Andres
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.